Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C for AKI Outcomes in Cirrhosis with MDR Infections
NCT04494451Completed
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Sep 2021
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of ascorbic acid in acute kidney injury (AKI) (2 arms), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: AKI progression at day 5. Started Sep 2021; status: completed.
02
Drugs
ascorbic acid
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT04494451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04494451.